Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs

Multiple Sclerosis

Volumn 10, Issue 1, 2004, Pages 5-8

  Oturai, Annette Bang ^a   Ryder, Lars P ^a   Fredrikson, Sten ^b   Myhr, Kjell Morten ^c   Celius, Elisabeth G ^d   Harbo, Hanne Flinstad ^e   Andersen, Oluf ^f   Åkesson, Eva ^b   Hillert, Jan ^b   Madsen, Hans O ^a   Nyland, Harald ^c   Spurkland, Anne ^e   Datta, Pameli ^a   Svejgaard, Arne ^a   Sorensen, Per S ^a  

^a Rigshospitalet   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Clinical features; HLA; Multiple sclerosis; Sib pairs

Indexed keywords

HLA DR2 ANTIGEN;

ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; DISEASE CARRIER; DISEASE COURSE; FAMILY SIZE; FEMALE; GENE CONTROL; GENETIC ANALYSIS; GENETIC ASSOCIATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; POPULATION RESEARCH; SCANDINAVIA; SIBLING; STATISTICAL ANALYSIS;

EID: 0347337779     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245850ms975oa     Document Type: Article

References (38)

1. Sadovnick AD, Armstrong H, Rice GP, Bulman D, Hashimoto L, Paty DW et al. A population-based study of multiple sclerosis in twins: Update. Ann Neurol 1933; 33: 281-85.
2. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11-15.
3. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995; 377: 150-51.
4. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-30.
5. Robertson NP, O'Riordan JI, Chataway J, Kingsley DP, Miller DH, Clayton D et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997; 349: 1587-90.
6. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: Updated risks for relatives. Am J Med Genet 1988; 29: 533-41.
7. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: An overview. Neurology 1980; 30: 61-79.
8. Poser CM. The dissemination of multiple sclerosis: A Viking saga? A historical essay. Ann Neurol 1994; 36 (suppl. 2): S231-S243.
9. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimm 1994; 54: 1-17.
10. Koch-Henriksen N, Bronnum-Hansen H, Hyllested K. Incidence of multiple sclerosis in Denmark 1948-1982: A descriptive nationwide study. Neuroepidemiology 1992; 11: 1-10.
11. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998; 2: 24-33.
12. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nature Genet 1996; 13: 469-71.
13. Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S et al. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999; 46: 612-16.
14. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci 2000; 178: 132-35.
15. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Moller E et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989; 86: 7113-17.
16. Weinshenker BG, Santrach P, Bissonet AS, McDonnell SK, Schaid D, Moore SB et al. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study. Neurology 1998; 51: 742-47.
17. Weitkamp LR. Multiple sclerosis susceptibility. Interaction between sex and HLA. Arch Neurol 1983; 40: 399-401.
18. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
20. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-11.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
22. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In Tsuji K, Aizawa M, Sasazuki T eds. HLA 1991, Volume I. Oxford: Oxford University Press, 1992: 397-419.
23. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-52.
24. Bulman E, Sadovnick AD, Ebers GC. Age of onset in siblings concordant for multiple sclerosis. Brain 1991; 114: 937-50.
25. Brassat D, Azais-Vuillemin C, Yaouang J, Semana G, Reboul J, Cournu I et al. Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group. Neurology 1999; 52: 1632-36.
26. Warren SA, Warren KG. Influence of gender on susceptibility to multiple sclerosis and age of onset in concordant sibships. Int J Epidemiol 1996; 25: 142-145.
27. Trojano M, Liguori M, De Robertis F, Stella A, Guanti G, Avolio C et al. Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families; Relation to tumour necrosis factor genomic polymorphisms. J Neurol Sci 1999; 162: 194-200.
28. Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM et al. Multiple sclerosis sibling pairs: Clustered onset and familial predisposition. Neurology 1990; 40: 1546-52.
29. Sadovnick AD. Familial recurrence risks and inheritance of multiple sclerosis. Curr Opin Neurol Neurosurg 1993; 6: 189-94.
30. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000; 48: 211-19.
31. Weatherby SJ, Thomson W, Pepper L, Donn R, Worthington J, Mann CL et al. HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 2001; 248: 304-10.
32. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996; 13: 464-68.
33. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13: 472-76.
34. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-1387.
35. The Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of genomic screens in multiple sclerosis. Mult Scler 2001; 7: 3-11.
36. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
37. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991; 29: 53-62.
38. Giordano M, D'Alfonso S, Momigliano-Richiardi P. Genetics of multiple sclerosis: Linkage and association studies. Am J Pharmacogenomics 2002; 2: 37-58.